Jefferies remains Buy-rated on HCA Holdings HCA and raises its price target by $4 to $34 as it believe the company's valuation to be depressed.
Jefferies says, "We could be in the early stages of a recovery in healthcare service utilization. If this is true, HCA, long considered the bellwether of the sector, is well positioned to outperform given its depressed valuation. HCA's dynamic cash flows could be harnessed to drive upside performance."
HCA closed at $27.80 a share yesterday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in